[go: up one dir, main page]

FR2968305B1 - Procede de preparation d'un gel reticule - Google Patents

Procede de preparation d'un gel reticule

Info

Publication number
FR2968305B1
FR2968305B1 FR1060135A FR1060135A FR2968305B1 FR 2968305 B1 FR2968305 B1 FR 2968305B1 FR 1060135 A FR1060135 A FR 1060135A FR 1060135 A FR1060135 A FR 1060135A FR 2968305 B1 FR2968305 B1 FR 2968305B1
Authority
FR
France
Prior art keywords
reticulated gel
preparing
preparing reticulated
gel
reticulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1060135A
Other languages
English (en)
Other versions
FR2968305A1 (fr
Inventor
Stephane Meunier
Francois Bourdon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teoxane SA
Original Assignee
Teoxane SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44265691&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2968305(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teoxane SA filed Critical Teoxane SA
Priority to FR1060135A priority Critical patent/FR2968305B1/fr
Priority to CA2817837A priority patent/CA2817837C/fr
Priority to RU2013125786/05A priority patent/RU2590558C2/ru
Priority to BR112013012251-0A priority patent/BR112013012251B1/pt
Priority to PL11799874T priority patent/PL2649101T3/pl
Priority to PCT/IB2011/055495 priority patent/WO2012077054A1/fr
Priority to KR1020137017022A priority patent/KR101868183B1/ko
Priority to ES11799874T priority patent/ES2883135T3/es
Priority to JP2013542654A priority patent/JP5860060B2/ja
Priority to DK11799874.0T priority patent/DK2649101T3/da
Priority to PT117998740T priority patent/PT2649101T/pt
Priority to AU2011340106A priority patent/AU2011340106B2/en
Priority to US13/989,197 priority patent/US9393189B2/en
Priority to EP11799874.0A priority patent/EP2649101B1/fr
Publication of FR2968305A1 publication Critical patent/FR2968305A1/fr
Publication of FR2968305B1 publication Critical patent/FR2968305B1/fr
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/02Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075Macromolecular gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91Injection
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
FR1060135A 2010-12-06 2010-12-06 Procede de preparation d'un gel reticule Active FR2968305B1 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR1060135A FR2968305B1 (fr) 2010-12-06 2010-12-06 Procede de preparation d'un gel reticule
JP2013542654A JP5860060B2 (ja) 2010-12-06 2011-12-06 架橋ゲルの製造方法
PT117998740T PT2649101T (pt) 2010-12-06 2011-12-06 Processo de preparação de um gel reticulado
BR112013012251-0A BR112013012251B1 (pt) 2010-12-06 2011-12-06 processo de preparação de um gel reticulado
PL11799874T PL2649101T3 (pl) 2010-12-06 2011-12-06 Sposób wytwarzania usieciowanego żelu
PCT/IB2011/055495 WO2012077054A1 (fr) 2010-12-06 2011-12-06 Procédé de préparation d'un gel réticulé
KR1020137017022A KR101868183B1 (ko) 2010-12-06 2011-12-06 가교된 겔의 제조 공정
ES11799874T ES2883135T3 (es) 2010-12-06 2011-12-06 Proceso para preparar un gel reticulado
CA2817837A CA2817837C (fr) 2010-12-06 2011-12-06 Procede de preparation d'un gel reticule
DK11799874.0T DK2649101T3 (da) 2010-12-06 2011-12-06 Fremgangsmåde til fremstilling af en tværbundet gel
RU2013125786/05A RU2590558C2 (ru) 2010-12-06 2011-12-06 Способ получения поперечно-сшитого геля
AU2011340106A AU2011340106B2 (en) 2010-12-06 2011-12-06 Process of preparing a cross linked gel
US13/989,197 US9393189B2 (en) 2010-12-06 2011-12-06 Process of preparing a crosslinked gel
EP11799874.0A EP2649101B1 (fr) 2010-12-06 2011-12-06 Procédé de préparation d'un gel réticulé

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1060135A FR2968305B1 (fr) 2010-12-06 2010-12-06 Procede de preparation d'un gel reticule

Publications (2)

Publication Number Publication Date
FR2968305A1 FR2968305A1 (fr) 2012-06-08
FR2968305B1 true FR2968305B1 (fr) 2014-02-28

Family

ID=44265691

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1060135A Active FR2968305B1 (fr) 2010-12-06 2010-12-06 Procede de preparation d'un gel reticule

Country Status (14)

Country Link
US (1) US9393189B2 (fr)
EP (1) EP2649101B1 (fr)
JP (1) JP5860060B2 (fr)
KR (1) KR101868183B1 (fr)
AU (1) AU2011340106B2 (fr)
BR (1) BR112013012251B1 (fr)
CA (1) CA2817837C (fr)
DK (1) DK2649101T3 (fr)
ES (1) ES2883135T3 (fr)
FR (1) FR2968305B1 (fr)
PL (1) PL2649101T3 (fr)
PT (1) PT2649101T (fr)
RU (1) RU2590558C2 (fr)
WO (1) WO2012077054A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2703109C (fr) 2007-11-16 2017-07-18 Vicept Therapeutics, Inc. Compositions et procedes de traitement du purpura
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
AU2009288118B2 (en) 2008-09-02 2014-12-11 Allergan, Inc. Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
FR2945293B1 (fr) * 2009-05-11 2011-06-17 Teoxane Procede de preparation d'un gel reticule.
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
FR2957254B1 (fr) 2010-03-12 2016-10-14 Allergan Ind Sas Compositions fluides pour ameliorer les etats de la peau
CA2794254C (fr) 2010-03-22 2018-09-04 Allergan, Inc. Hydrogels reticules a base de polysaccharides et de proteines- polysaccharides pour l'augmentation des tissus mous
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
KR102312056B1 (ko) 2011-06-03 2021-10-12 알러간 인더스트리 에스에이에스 항산화제를 포함하는 피부 충전제 조성물
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
ES2761558T3 (es) 2014-09-30 2020-05-20 Allergan Ind Sas Composiciones de hidrogel estables que incluyen aditivos
FR3029928B1 (fr) 2014-12-15 2018-03-09 Teoxane Gel reticule
BR112017017346B1 (pt) 2015-02-13 2021-09-08 Allergan Industrie, Sas Composição estéril, implantável de modo subdérmico ou supraperiosteal na área de queixo, linha da mandíbula ou nariz, usos de uma quantidade eficaz de ácido hialurônico (ha) reticulado com bdde e kit
FR3034195B1 (fr) * 2015-03-24 2017-04-21 Teoxane Procede d'evaluation des performances mecaniques d'un gel de comblement
FR3066386B1 (fr) * 2017-05-18 2020-08-28 Bioxis Pharmaceuticals Procede de preparation d'un gel aqueux d'acide hyaluronique
US12251397B2 (en) 2018-02-06 2025-03-18 Regen Lab Sa Cross-linked hyaluronic acids and combinations with PRP/BMC
KR20200046649A (ko) 2018-10-25 2020-05-07 (주)뉴크레이티브랩 혼합상 히알루론산 제조방법
FR3146899A1 (fr) 2023-03-21 2024-09-27 Teoxane SA Procédé de préparation d’un hydrogel stérile comprenant un polysaccharide réticulé, non réticulé ou leur mélange
FR3146900A1 (fr) 2023-03-21 2024-09-27 Teoxane SA Procédé de préparation d’un hydrogel stérile comprenant un polysaccharide réticulé, non réticulé ou leur mélange
WO2025125597A1 (fr) 2023-12-15 2025-06-19 Teoxane SA Hydrogel à base de polysaccharide comprenant du silicium

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902652D0 (en) * 1999-02-05 1999-03-31 Fermentech Med Ltd Process
FR2811996B1 (fr) 2000-07-19 2003-08-08 Corneal Ind Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
TW574301B (en) * 2001-05-02 2004-02-01 Ind Tech Res Inst Manufacturing method of epoxide crosslinked polysaccharides matrix
DE10223310A1 (de) 2002-05-24 2003-12-11 Biotronik Mess & Therapieg Verfahren zum Beschichten von Implantaten mit einer Polysaccharid-Lage
TWI251596B (en) * 2002-12-31 2006-03-21 Ind Tech Res Inst Method for producing a double-crosslinked hyaluronate material
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
US8524213B2 (en) 2003-12-30 2013-09-03 Genzyme Corporation Polymeric materials, their preparation and use
FR2865737B1 (fr) * 2004-02-03 2006-03-31 Anteis Sa Gel reticule biocompatible
US20050226936A1 (en) * 2004-04-08 2005-10-13 Q-Med Ab Method of soft tissue augmentation
CA2567532C (fr) * 2004-05-20 2013-10-01 Mentor Corporation Procede de preparation d'hydrogels polymeres injectables
CN101056891B (zh) * 2004-11-15 2010-05-26 株式会社资生堂 交联透明质酸凝胶的制备方法
US20060105022A1 (en) 2004-11-15 2006-05-18 Shiseido Co., Ltd. Process for preparing crosslinked hyaluronic acid gel
CN101107270B (zh) 2004-11-24 2011-11-23 诺维信生物制药丹麦公司 用二乙烯基砜交联透明质酸的方法
CN101153061A (zh) 2006-09-29 2008-04-02 北京普麦迪克生物技术研究所 一种透明质酸及其二次交联形成凝胶的方法
FR2908775B1 (fr) * 2006-11-17 2012-08-31 Biomatlante Hydrogel et ses applications biomedicales
JP5071766B2 (ja) 2006-12-08 2012-11-14 独立行政法人日本原子力研究開発機構 多糖類を原料とするゲルの製造方法
FR2924615B1 (fr) * 2007-12-07 2010-01-22 Vivacy Lab Hydrogel cohesif biodegradable.
US8450475B2 (en) 2008-08-04 2013-05-28 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
DK2236523T3 (en) 2009-03-30 2018-05-07 Scivision Biotech Inc Process for the preparation of crosslinked hyaluronic acid
FR2945293B1 (fr) 2009-05-11 2011-06-17 Teoxane Procede de preparation d'un gel reticule.
IT1395392B1 (it) 2009-08-27 2012-09-14 Fidia Farmaceutici Geli viscoelastici come nuovi filler
EP3138586B1 (fr) 2010-11-08 2021-01-06 Allergan Industrie, SAS Charges de tissus mous

Also Published As

Publication number Publication date
EP2649101B1 (fr) 2021-06-02
AU2011340106A1 (en) 2013-06-06
WO2012077054A1 (fr) 2012-06-14
AU2011340106B2 (en) 2016-03-03
RU2013125786A (ru) 2015-01-20
PL2649101T3 (pl) 2021-11-22
DK2649101T3 (da) 2021-08-16
JP5860060B2 (ja) 2016-02-16
KR20130132510A (ko) 2013-12-04
RU2590558C2 (ru) 2016-07-10
US9393189B2 (en) 2016-07-19
ES2883135T3 (es) 2021-12-07
BR112013012251B1 (pt) 2021-02-09
EP2649101A1 (fr) 2013-10-16
CA2817837A1 (fr) 2012-06-14
US20130237615A1 (en) 2013-09-12
PT2649101T (pt) 2021-08-05
KR101868183B1 (ko) 2018-06-15
JP2013544944A (ja) 2013-12-19
FR2968305A1 (fr) 2012-06-08
CA2817837C (fr) 2019-07-09
BR112013012251A2 (pt) 2016-08-09

Similar Documents

Publication Publication Date Title
FR2968305B1 (fr) Procede de preparation d'un gel reticule
FR2968306B1 (fr) Procede de preparation d'un gel reticule
FR2945293B1 (fr) Procede de preparation d'un gel reticule.
FR2991320B1 (fr) Procede de preparation d'amines methylees
FR2997085B1 (fr) Procede de preparation d'un gel reticule
FR2990217B1 (fr) Procede d'obtention de peptides
FR2960167B1 (fr) Procede d'obtention de couches minces
EP2770955A4 (fr) Système d'implant intercorporel pivotant
FR2958291B1 (fr) Procede de preparation de derives d'amino-benzofurane
FR2958289B1 (fr) Procede de preparation de derives de 3-ceto-benzofurane
EP2787982A4 (fr) Procédé de préparation de l'intestin
FR2962731B1 (fr) Procede de preparation de derives d'amino-benzoyl-benzofurane
FI20105640A7 (fi) Menetelmä mikroselluloosan valmistamiseksi
FR2963006B1 (fr) Procede de preparation de derives de nitro-benzofurane
FR2958290B1 (fr) Procede de preparation de derives de sulfonamido-benzofurane
FR2948535B1 (fr) Procede de preparation de pollen brut
FR2983316B1 (fr) Procede de preparation d'une lentille ophtalmique
FR2966150B1 (fr) Procede de preparation de la 2-hydroxybutyrolactone
FR2993881B1 (fr) Procede de preparation d'alkoxyphenol et d'alkoxyhydroxybenzaldehyde
FR2993882B1 (fr) Procede de preparation d'alkoxyhydroxybenzaldehyde sensiblement exempte d'alkyl-alkoxyhydroxybenzaldehyde
FR2974452B1 (fr) Procede de preparation d'une demi-cellule electrochimique
EP2594552A4 (fr) Procédé de préparation de la ramaline
EP2627647A4 (fr) Procédés de préparation de lubiprostone
FR2977585B1 (fr) Procede de preparation d'esters
FR2980795B1 (fr) Procede de preparation de galactomannanes cationiques

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

LIMR Limitation of claims

Effective date: 20220610

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16